ERS International Congress, Paris 2018

Browse by day:
Saturday, 15.09.2018
Sunday, 16.09.2018
Monday, 17.09.2018
Tuesday, 18.09.2018
Wednesday, 19.09.2018

 

View the presentations you missed during Congress!

More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available. 

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.


Novel immunology-based therapies in asthma and COPD

Oral Presentation
Chairs: A. Bossios (Stockholm, Sweden), M. Idzko (Vienna, Austria)
Late Breaking Abstract - Pharmacological characterization of T cell-induced broncho-constriction in vitro and in vivo
A. Mori (Sagamihara, Japan), S. Kouyama (Sagamihara, Japan), M. Yamaguchi (Sagamihara, Japan), C. Kumitani (Sagamihara, Japan), A. Ohtomo-Abe (Sagamihara, Japan), N. Fujita (Sagamihara, Japan), M. Iwata (Sagamihara, Japan), K. Nagayama (Sagamihara, Japan), K. Ryu (Sagamihara, Japan), Y. Nakamura (Sagamihara, Japan), Y. Tomita (Sagamihara, Japan), Y. Hamada (Sagamihara, Japan), H. Hayashi (Sagamihara, Japan), K. Watai (Sagamihara, Japan), Y. Kamide (Sagamihara, Japan), K. Sekiya (Sagamihara, Japan), Y. Fukutomi (Sagamihara, Japan), M. Taniguchi (Sagamihara, Japan), T. Ohtomo (Hachioji, Japan), O. Kaminuma (Chuo, Japan)
Congress or journal article abstractSlide presentationWebcast
Congress or journal article abstractSlide presentationWebcast
IL-37 ameliorates experimental asthma by inhibiting IL-1
A. Schroeder (Borstel, Germany), L. Lunding (Borstel, Germany), C. Vock (Borstel, Germany), B. Schaub (Munich, Germany), U. Zissler (Munich, Germany), H. Fehrenbach (Borstel, Germany), M. Wegmann (Borstel, Germany)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Alamandine reduces eosinophilic inflammation in an experimental model of asthma
J. Gregório (Belo Horizonte, Brazil), G. Magalhães (Belo Horizonte, Brazil), G. Rodrigues-Machado (Belo Horizonte, Brazil), K. Gonzaga (Belo Horizonte, Brazil), A. Oliveira (Belo Horizonte, Brazil), F. Souza-Neto (Belo Horizonte, Brazil), B. Rezende (Belo Horizonte, Brazil), V. Pinho (Belo Horizonte, Brazil), L. Barcelos (Belo Horizonte, Brazil), R. Da Silva (Belo Horizonte, Brazil), R. Santos (Belo Horizonte, Brazil), M. Campagnole-Santos (Belo Horizonte, Brazil)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics
J. Nieto-Fontarigo (Santiago de Compostela, Spain), F. Salgado-Castro (Santiago de Compostela, Spain), M. San-José-Capilla (Santiago de Compostela, Spain), J. Carreira-Villamor (Santiago de Compostela, Spain), L. Valdés-Cuadrado (Santiago de Compostela, Spain), A. Faraldo-García (Santiago de Compostela, Spain), M. García-González (Santiago de Compostela, Spain), C. Diego-Roza (Ferrol, Spain), P. Martín-Lancharro (Santiago de Compostela, Spain), J. Moure-González (Santiago de Compostela, Spain), T. Liñares-Mata (Pontevedra, Spain), E. Takkouche-Souilamas (Santiago de Compostela, Spain), P. Arias (Santiago de Compostela, Spain), M. Nogueira (Santiago de Compostela, Spain), F. González-Barcala (Santiago de Compostela, Spain)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program
H. Ortega (La Jolla, CA, United States of America), E. Meyer (Philadelphia, PA, United States of America), G. Brusselle (Ghent, Belgium), K. Asano (Kanagawa, Japan), R. Price (Stevenage, Hertfordshire, United Kingdom), C. Prazma (Research Triangle Park, NC, United States of America), F. Albers (Research Triangle Park, NC, United States of America), S. Yancey (Research Triangle Park, NC, United States of America), G. Gleich (Utah, United States of America)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Dupilumab efficacy in asthma patients with comorbid chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST
I. Pavord (Oxford, United Kingdom), L. Ford (Bellevue, United States of America), L. Sher (Rolling Hills Estates, United States of America), K. Rabe (Kiel, Germany), H. Park (Seoul, Republic of Korea), B. Cosio (Palma de Mallorca, Spain), M. Foster (Bridgewater, United States of America), H. Staudinger (Bridgewater, United States of America), J. Maroni (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), G. Pirozzi (Bridgewater, United States of America), M. Ruddy (Tarrytown, United States of America), B. Akinlade (Tarrytown, United States of America), N. H. Graham (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Tryptase loss-of-function mutations reduce tryptase expression and predict asthmatic response to anti-IgE therapy
D. Choy (South San Francisco, United States of America), N. Trivedi (San Francisco, United States of America), A. Dressen (South San Francisco, United States of America), M. Babina (Berlin, Germany), R. Ahuja (San Francisco, United States of America), T. Yi (South San Francisco, United States of America), J. Jackman (South San Francisco, United States of America), G. Ji (South San Francisco, United States of America), J. Hackney (South San Francisco, United States of America), L. Orozco-Guerra (South San Francisco, United States of America), D. Chang (South San Francisco, United States of America), G. Caughey (San Francisco, United States of America), B. Yaspan (San Francisco, United States of America)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Systemic immunological changes following intravenous mesenchymal stromal cell infusion in stable COPD patients
J. Armitage (Perth, Australia), D. Tan (Perth, Australia), R. Troedson (Perth, Australia), P. Young (Perth, Australia), K. Lam (Perth, Australia), K. Shaw (Perth, Australia), M. Sturm (Perth, Australia), D. Weiss (Vermont, United States of America), Y. Moodley (Perth, Australia)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation